pomalid 4mg

Pomalid 4mg is a prescription medication used to treat certain types of multiple myeloma, a type of blood cancer. It is a immunomodulatory agent that works by:

1. Increasing the activity of the immune system to attack cancer cells.
2. Reducing the production of new blood vessels that feed the tumor, which helps to reduce its growth and spread.

Composition:

• Pomalid 4mg: Pomalidomide 4mg

Indications:

Pomalid is approved for the treatment of:

1. Multiple myeloma in patients who have received at least two prior therapies, including bortezomib and lenalidomide.
2. Multiple myeloma in patients who have received at least three prior therapies, including bortezomib and lenalidomide.

Dosage:

The recommended dosage of Pomalid is:

• 4mg orally once daily, taken with a meal and at the same time every day.
• The recommended duration of treatment is until disease progression or unacceptable toxicity.

Side Effects:

Common side effects of Pomalid include:

1. Fatigue
2. Neutropenia (low white blood cell count)
3. Anemia (low red blood cell count)
4. Thrombocytopenia (low platelet count)
5. Constipation
6. Diarrhea
7. Nausea
8. Vomiting
9. Increased risk of bleeding or bruising
10. Skin rash
11. Hair loss

Recommendation:

Pomalid is recommended for patients who have been diagnosed with multiple myeloma and have not responded to other treatments or have disease that has progressed after surgery and radiation therapy.

Important Note:

• Patients taking Pomalid should be closely monitored for signs of bleeding or bruising due to the risk of low blood counts.
• Patients taking Pomalid should avoid taking medications that may increase the risk of bleeding or bruising.
• Pregnant or breastfeeding women should not use Pomalid, as it may harm the fetus or infant.
• Regular follow-up appointments with your healthcare provider are necessary to monitor the effectiveness of Pomalid and to detect any potential side effects or complications.

Special Precautions:

• Patients with a history of kidney disease should be closely monitored for signs of worsening kidney function while taking Pomalid.
• Patients taking Pomalid should avoid taking medications that may interact with it, such as anticoagulants or medications that can increase the risk of bleeding.
• Patients with a history of heart disease or high blood pressure should be closely monitored while taking Pomalid.

Pregnancy and Breastfeeding:

• Pregnant women should not take Pomalid, as it may cause harm to the fetus.
• Breastfeeding women should not take Pomalid, as it may pass into breast milk and harm the infant.

Contraindications:

• Patients with a history of severe hypersensitivity reactions to pomalidomide or other immunomodulatory agents.
• Patients with a history of leptomeningeal carcinomatosis (cancer spread to the brain).
• Patients with a history of severe hepatic impairment (liver disease).